Angiotensin Type 1 Receptor Blockers Induce Peroxisome Proliferator–Activated Receptor-γ Activity
Top Cited Papers
- 4 May 2004
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (17), 2054-2057
- https://doi.org/10.1161/01.cir.0000127955.36250.65
Abstract
Background— Angiotensin type 1 receptor (AT1R) blockers (ARB) have been shown to reduce the incidence of type 2 diabetes mellitus by an unknown molecular mechanism. The peroxisome proliferator–acti...Keywords
This publication has 8 references indexed in Scilit:
- Insulin-Induced Akt Activation Is Inhibited by Angiotensin II in the Vasculature Through Protein Kinase C-αHypertension, 2003
- PPARα Inhibits TGF-β–Induced β 5 Integrin Transcription in Vascular Smooth Muscle Cells by Interacting With Smad4Circulation Research, 2002
- ACE Inhibitor Improves Insulin Resistance in Diabetic Mouse Via Bradykinin and NOHypertension, 2002
- Role of Peroxisome Proliferator-Activated Receptor-γ in Maintenance of the Characteristics of Mature 3T3-L1 AdipocytesDiabetes, 2002
- PPARγANDGLUCOSEHOMEOSTASISAnnual Review of Nutrition, 2002
- Mature Adipocytes Inhibit In Vitro Differentiation of Human Preadipocytes via Angiotensin Type 1 ReceptorsDiabetes, 2002
- Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenololThe Lancet, 2002
- Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertensionJournal of Human Hypertension, 2000